BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31314604)

  • 1. Initial systemic chemotherapeutic and targeted therapy strategies for the treatment of colorectal cancer patients with liver metastases.
    Saad AM; Abdel-Rahman O
    Expert Opin Pharmacother; 2019 Oct; 20(14):1767-1775. PubMed ID: 31314604
    [No Abstract]   [Full Text] [Related]  

  • 2. Topics related to neoadjuvant chemotherapy for resectable liver metastases from colorectal cancer.
    Ke S; Zhan S; Zhu H; Yan D
    J BUON; 2018; 23(2):296-301. PubMed ID: 29745068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated options for liver-limited metastatic colorectal cancer.
    Alberts SR
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S58-62. PubMed ID: 19064408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Sabanathan D; Eslick GD; Shannon J
    Clin Colorectal Cancer; 2016 Dec; 15(4):e141-e147. PubMed ID: 27174607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of synchronous colorectal liver metastases].
    Dupré A; Gagnière J; Chen Y; Rivoire M
    Bull Cancer; 2013 Apr; 100(4):363-71. PubMed ID: 23559319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
    Ihnát P; Vávra P; Zonča P
    World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases.
    Davies JM; Goldberg RM
    J Surg Oncol; 2010 Dec; 102(8):946-54. PubMed ID: 21165997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.
    Alberts S; Poston G
    Colorectal Dis; 2003 Nov; 5 Suppl 3():20-8. PubMed ID: 23573557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial.
    Chen HH; Lin JK; Chen JB; Chuang CH; Liu MC; Wang JY; Changchien CR
    Asia Pac J Clin Oncol; 2018 Feb; 14(1):61-68. PubMed ID: 28906589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer.
    Mandalà M; Mosconi S; Quadri A; Milesi L; Labianca R
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):887-97. PubMed ID: 17555399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of chemotherapy in managing patients with resectable liver metastases.
    Halfdanarson TR; Kendrick ML; Grothey A
    Cancer J; 2010; 16(2):125-31. PubMed ID: 20404609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).
    Huiskens J; van Gulik TM; van Lienden KP; Engelbrecht MR; Meijer GA; van Grieken NC; Schriek J; Keijser A; Mol L; Molenaar IQ; Verhoef C; de Jong KP; Dejong KH; Kazemier G; Ruers TM; de Wilt JH; van Tinteren H; Punt CJ
    BMC Cancer; 2015 May; 15():365. PubMed ID: 25943574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
    Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
    Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of liver-limited metastatic colorectal cancer.
    Hubbard JM; Alberts SR
    Cancer J; 2010; 16(3):235-40. PubMed ID: 20526102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.
    Brouquet A; Nordlinger B
    Scand J Gastroenterol; 2012 Mar; 47(3):286-95. PubMed ID: 22182353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Timing of resection in patients with colorectal carcinoma and synchronous liver metastases].
    Hopt UT; Drognitz O; Neeff H
    Zentralbl Chir; 2009 Sep; 134(5):425-9. PubMed ID: 19757342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment for synchronous liver metastasis of colorectal cancer].
    Scripcariu V; Roşca MG
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):442-52. PubMed ID: 21495350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases.
    Pietrantonio F; Mazzaferro V; Miceli R; Cotsoglou C; Melotti F; Fanetti G; Perrone F; Biondani P; Muscarà C; Di Bartolomeo M; Coppa J; Maggi C; Milione M; Tamborini E; de Braud F
    Med Oncol; 2015 Jul; 32(7):182. PubMed ID: 26003673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.